DermTech, a privately held biotechnology company developing and commercializing qPCR assays for skin samples collected non-invasively using adhesive patch methods, announced today that its abstract entitled “Reproducibility and accuracy of cross platform rtqPCR testing for the detection of mRNA from surface squamous cells overlying pigmented skin lesions” has been accepted and will be presented by Dr. Howard Robin at the 2013 Annual Association for Molecular Pathology Meeting to be held November 14-16, 2013 at the Phoenix Convention Center.
Help employers find you! Check out all the jobs and post your resume.
